Safety and Efficacy Study for DC Vaccine in Recurrent or Progressive High-grade Gliomas

NCT06253234 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

12

Enrollment

OTHER

Sponsor class

Conditions

WHO Grade III Gliomas
WHO Grade IV Gliomas

Interventions

BIOLOGICAL: personalized dendritic cell injection ZSNeo-DC1.1

Sponsor

Beijing Tiantan Hospital

Collaborators

[object Object]